Advances in Organogelators: Preparation, Properties, and Applications

Dear Colleagues,

The design of gel-based materials, obtained from gelator molecules self-assembled into 3D network structures and entrapping various solvents, has gained research interest. Different low-molecular-weight organogelators (LMOG) or polymeric organogelators (POG) have been used to form in situ injectable gel materials. These systems are usually prepared by dissolving the gelator in a solvent medium and then cooling the solution below its characteristic gelation transition temperature (Tgel). Most hydrogel or organogel materials are physical gels and, unlike chemical gels (cross-linked polymers), are thermally sensitive and thermally reversible. In solution, gelators self-assemble via non-covalent interactions to form fibrous structures responsible for the gelation phenomena. One promising avenue for these gel materials used as depot formulations lies in the administration of hydrophilic and lipophilic drugs, such as cholinesterase inhibitors, vaccine adjuvants, contraceptive steroids, and anti-inflammatory and chemotherapeutic agents. They are also engineered to interact with biological systems for biomedical applications. Furthermore, another axis of research is developing a bio-inspired approach involving a bottom-up strategy for synthesizing supramolecular gels to generate novel biomaterial candidates. All these demonstrations show the importance of examining these materials and their derivatives for the preparation of new formulations or smart materials for pharmaceutical and medicinal applications.

The purpose of this Special Issue is to summarize the progress achieved regarding advanced organogelators and to encourage the discovery of new organogelators for different applications.

Dr. Plamen Kirilov
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gels is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• organogels
• drug delivery
• biomaterials
• device development
• pharmaceutics
• drug reservoirs
• smart delivery systems
• smart formulations